In this study, we found that pERK1/2 expression was downregulated and P-gp expression was upregulated in DDP-resistant cervical adenocarcinoma cells, suggesting that inhibition of the ERK1/2 pathway may play regulatory roles in the resistance of cervical adenocarcinoma cells. The gene discussed is PGP; the disease is cervical adenocarcinoma.